216 related articles for article (PubMed ID: 33437990)
1. Rare immunofluorescence patterns of autoantibodies on HEp-2 cells defined by ICAP identify different autoimmune diseases in the absence of associated specificities: a Spanish multicentre study.
Irure-Ventura J; Rodríguez C; Vergara-Prieto E; Vargas ML; Quirant B; Jurado A; Fernández-Pereira L; Martínez-Cáceres E; San José M; López-Hoyos M;
Rheumatology (Oxford); 2021 Aug; 60(8):3904-3912. PubMed ID: 33437990
[TBL] [Abstract][Full Text] [Related]
2. Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases.
Wei Q; Jiang Y; Xie J; Lv Q; Xie Y; Tu L; Xiao M; Wu Z; Gu J
J Clin Lab Anal; 2020 Dec; 34(12):e23546. PubMed ID: 33047841
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
Jeong S; Yang D; Lee W; Kim GT; Kim HS; Ahn HS; Kim HJ
Semin Arthritis Rheum; 2018 Oct; 48(2):334-342. PubMed ID: 29609799
[TBL] [Abstract][Full Text] [Related]
4. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
Lee H; Kim Y; Han K; Oh EJ
Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
[TBL] [Abstract][Full Text] [Related]
5. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
[TBL] [Abstract][Full Text] [Related]
6. Routine immunofluorescence detection of Ro/SS-A autoantibody using HEp-2 cells transfected with human 60 kDa Ro/SS-A.
Pollock W; Toh BH
J Clin Pathol; 1999 Sep; 52(9):684-7. PubMed ID: 10655991
[TBL] [Abstract][Full Text] [Related]
7. Range of antinuclear antibodies in "healthy" individuals.
Tan EM; Feltkamp TE; Smolen JS; Butcher B; Dawkins R; Fritzler MJ; Gordon T; Hardin JA; Kalden JR; Lahita RG; Maini RN; McDougal JS; Rothfield NF; Smeenk RJ; Takasaki Y; Wiik A; Wilson MR; Koziol JA
Arthritis Rheum; 1997 Sep; 40(9):1601-11. PubMed ID: 9324014
[TBL] [Abstract][Full Text] [Related]
8. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease.
Lyons R; Narain S; Nichols C; Satoh M; Reeves WH
Ann N Y Acad Sci; 2005 Jun; 1050():217-28. PubMed ID: 16014537
[TBL] [Abstract][Full Text] [Related]
9. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies.
Mahler M; Kim G; Roup F; Bentow C; Fabien N; Goncalves D; Palterer B; Fritzler MJ; Villalta D
Immunol Res; 2021 Jun; 69(3):239-248. PubMed ID: 33913080
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
[TBL] [Abstract][Full Text] [Related]
12. Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.
Landon-Cardinal O; Baril-Dionne A; Hoa S; Meyer A; Leclair V; Bourré-Tessier J; Mansour AM; Zarka F; Makhzoum JP; Nehme J; Rich E; Goulet JR; Grodzicky T; Koenig M; Joyal F; Richard I; Hudson M; Targoff I; Satoh M; Fritzler MJ; Troyanov Y; Senécal JL
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32892170
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease.
Frodlund M; Wetterö J; Dahle C; Dahlström Ö; Skogh T; Rönnelid J; Sjöwall C
Clin Exp Immunol; 2020 Mar; 199(3):245-254. PubMed ID: 31778219
[TBL] [Abstract][Full Text] [Related]
14. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
Riemekasten G; Hiepe F
Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
[No Abstract] [Full Text] [Related]
15. Importance of detection of SS-A/Ro autoantibody in screening immunofluorescence tests for autoantibodies to nuclear antigens.
Bylund DJ; Nakamura RM
J Clin Lab Anal; 1991; 5(3):212-8. PubMed ID: 2061745
[TBL] [Abstract][Full Text] [Related]
16. Testing for autoimmunity in humans.
D'Cruz D
Toxicol Lett; 2002 Feb; 127(1-3):93-100. PubMed ID: 12052646
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with rheumatic diseases].
Grypiotis P; Ruffatti A; Tonello M; Winzler C; Radu C; Zampieri S; Favaro M; Calligaro A; Todesco S
Reumatismo; 2002; 54(3):232-7. PubMed ID: 12404031
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile.
Spadaro A; Rinaldi T; Riccieri V; Taccari E; Valesini G
Clin Exp Rheumatol; 2002; 20(2):213-6. PubMed ID: 12051401
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of the clinical significance of Ro52/TRIM21 antibody and specific antinuclear antibody patterns by indirect immunofluorescence.
Liu K; Liao Y; Li P; Shi J
J Pak Med Assoc; 2024 Feb; 74(2):236-242. PubMed ID: 38419219
[TBL] [Abstract][Full Text] [Related]
20. [Modern look at the problems of investigation of antinuclear antibodies in systemic lupus erythematosus (literature review).].
Aleksandrova EN; Verizhnikova ZG; Novikov AA; Lukina GV
Klin Lab Diagn; 2018; 63(6):340-348. PubMed ID: 30702224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
